fashion -WSS

fashion

author：fashion 2025-10-02 22:58:16 - browse：6

A new lawsuit accuses the health insurer Cigna of denying claims in bulk. Julia Rendleman/Getty Images for Eventive Marketing

A new lawsuit accuses Cigna of using an algorithm to automatically deny claims in bulk instead of individually reviewing each case, putting patients on the hook for bills the health insurer otherwise would have paid.

The complaint filed Monday in the Eastern District of California says Cigna uses a system called PXDX to identify discrepancies between diagnoses and the tests and services it covers for those ailments. The company then allegedly denies claims in bulk without looking into each coverage request. California law requires insurers to give each claim a “thorough, fair, and objective investigation.”

Once the claims are denied, the company allegedly has its physician reviewers sign off on batches of denials without opening each patient’s files to conduct detailed reviews. The complaint cites a March ProPublica article, which found that over a period of two months in 2022, Cigna doctors denied over 300,000 requests for payment using PXDX, spending an average of 1.2 seconds “reviewing” each request. One doctor alone denied 121,000 claims in that time period, according to the article.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

focus

WSS

Physician executives need more than on

Doctor appointment wait times are getting worse

Bacterial infection may be ‘key event’ in endometriosis, study says

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Pfizer's Covid pill remains 89% effective in final analysis, company says

Bacterial infection may be ‘key event’ in endometriosis, study says

focus

fashion

focus

Duchenne breakthrough therapy leaves behind pioneering families

7 people shot in DC, police say

New air purifier tech could be key to improving indoor air quality

Colorectal cancer study finds potential in overlooked immune cell

Alkermes shareholders re

Why age limits for politicians are a terrible idea

Medical records are filled with copy

Liquid biopsy for lung cancer is launched by Delfi

Novavax promises a turnaround & Lilly roils the obesity market

Meta looks to target Twitter with a rival app called Threads

focus

Liquid biopsy for lung cancer is launched by Delfi

Liquid biopsy for lung cancer is launched by Delfi

Option Care buys Amedisys in $3.6 billion home care deal

VC firm General Catalyst wants to buy a health system

Phenylephrine and the overlooked value of the placebo effect

Was Amgen transparent enough on FDA's concern on cancer drug?

Wikipedia

focus

focus

focus